Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: What is the role of isoniazid?

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 6, 2013, Pages 849-850

  Velayati, Ali Akbar ^a   Farnia, Parissa ^a   Masjedi, Mohammad Reza ^b   Hoffner, Sven ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ETHIONAMIDE; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CROSS RESISTANCE; DNA EXTRACTION; DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; HUMAN; INHA GENE; IRAN; KATG GENE; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPUTUM SMEAR;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; IRAN; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84878309232     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0066     Document Type: Letter

References (5)

1. Ioannidis P, Papaventsis D, Karabela S, et al. Cepheid Gene Xpert MTB/RIF assay for M. tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. J Clin Microbiol 2011; 49: 3068-3070.
2. World Health Organization. Rapid implementation of Xpert MTB/RIF diagnostic test. Technical and operational 'how-to' practical considerations. WHO/HTM/TB/2011.2. Geneva, Switzerland: WHO, 2011. http://whqlibdoc.who.int/ publications/2011/9789241501569-eng.pdf Accessed April 2013.
3. Sandman L, Schluger N W, Davidow A L, Bonk S. Risk factors for rifampin-monoresistant tuberculosis: a case-control study. Am J Respir Crit Care Med 1999; 159: 468-472. (Pubitemid 29084867)
4. Mukinda F K, Theron D, van der Spuy G D, et al. Rise in r ifampicin-monoresistant tuberculosis in Western Cape, South Africa. Int J Tuberc Lung Dis 2012; 16: 196-202.
5. Mirsaeidi S M, Tabarsi P, Khoshnood K, et al. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. Int J Infect Dis 2005; 9: 317-322. (Pubitemid 41476422)